113 related articles for article (PubMed ID: 10063359)
1. Clinical importance of c-Met protein expression in high grade astrocytic tumors.
Hirose Y; Kojima M; Sagoh M; Hayashi T; Murakami H; Shimazaki K; Yoshida K; Kawase T
Neurol Med Chir (Tokyo); 1998 Dec; 38(12):851-8; discussion 858-9. PubMed ID: 10063359
[TBL] [Abstract][Full Text] [Related]
2. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
[TBL] [Abstract][Full Text] [Related]
3. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
Kamiya M; Nakazato Y
Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
[TBL] [Abstract][Full Text] [Related]
4. [Factors affecting the prognosis of brain tumors].
Yoshimine T; Hayakawa T; Mogami H
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2022-7. PubMed ID: 2840033
[TBL] [Abstract][Full Text] [Related]
5. Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival.
Korkolopoulou P; Levidou G; El-Habr EA; Adamopoulos C; Fragkou P; Boviatsis E; Themistocleous MS; Petraki K; Vrettakos G; Sakalidou M; Samaras V; Zisakis A; Saetta A; Chatziandreou I; Patsouris E; Piperi C
Br J Cancer; 2013 May; 108(10):2142-52. PubMed ID: 23619925
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical examination of c-Met protein expression in astrocytic tumors.
Hirose Y; Kojima M; Sagoh M; Murakami H; Yoshida K; Shimazaki K; Kawase T
Acta Neuropathol; 1998 Apr; 95(4):345-51. PubMed ID: 9560011
[TBL] [Abstract][Full Text] [Related]
7. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors.
Khalid H; Shibata S; Kishikawa M; Yasunaga A; Iseki M; Hiura T
Cancer; 1997 Dec; 80(11):2133-40. PubMed ID: 9392336
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
13. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors.
Iwata S; Nakagawa K; Harada H; Oka Y; Kumon Y; Sakaki S
Neurosurgery; 1999 Jul; 45(1):24-8; discussion 29. PubMed ID: 10414562
[TBL] [Abstract][Full Text] [Related]
15. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system.
Ren Y; Munyer P; Kepes JJ; Cansler M; Collins J; Gayed B; Tawfik O
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):14-8. PubMed ID: 11277408
[TBL] [Abstract][Full Text] [Related]
17. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].
Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
Brain Nerve; 2009 Jul; 61(7):765-72. PubMed ID: 19618853
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approach.
Senetta R; Mellai M; Manini C; Castellano I; Bertero L; Pittaro A; Schiffer D; Boldorini R; Cassoni P
Histopathology; 2016 Aug; 69(2):329-37. PubMed ID: 26845757
[TBL] [Abstract][Full Text] [Related]
20. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
Perry A; Aldape KD; George DH; Burger PC
Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
